SPP1 and breast carcinoma: For example, blocking OPN binding to αvβ3 inhibited OPN-induced tumor growth and angiogenesis [139], decreased the expression of ILK, uPA, and MMP-2 [229], and prevented OPN-mediated AP-1 activation in breast cancer cells [230].